Nasdaq

Cepheid Announces World Health Organization Prequalification of the Xpert® MTB/XDR test

SUNNYVALE, Calif., Oct. 28, 2025 /PRNewswire/ -- Cepheid today announced that its Xpert® MTB/XDR test has been awarded prequalification status by the World Health Organization (WHO), marking a new ...
Nasdaq

Cepheid Announces World Health Organization Prequalification of Xpert HIV-1 Qualitative Test

SUNNYVALE, Calif., April 3, 2024 /PRNewswire/ -- Cepheid today announced that Xpert® HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification. Inclusion on the prequalification ...
Business Insider

Cepheid Receives Emergency Use Authorization from FDA for Xpert® Mpox

SUNNYVALE, Calif., Feb. 14, 2023 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration for Xpert Mpox, which runs on ...
Pharmabiz

Henry Schein to distribute Cepheid's GeneXpert System in US

Cepheid, a leading molecular diagnostics company, announced an agreement with Henry Schein Medical, the US Medical business of Henry Schein, Inc., for the distribution of its GeneXpert System and menu ...
Seeking Alpha

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost

New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global ...
Hosted on MSN

FDA clears Cepheid’s Xpert GI panel for pathogen detection

Cepheid has received clearance from the US Food and Drug Administration (FDA) for its Xpert GI Panel, a multiplex polymerase chain reaction (PCR) gastrointestinal (GI) pathogen testing solution. The ...